A. Zivelin

发表

Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes.

U Seligsohn, A. Zivelin, N. Rosenberg, 1997, Clinical chemistry.

Prerequisites for recombinant factor VIIa‐induced thrombin generation in plasmas deficient in factors VIII, IX or XI

U. Martinowitz, A. Zivelin, U. Seligsohn, 2006, Journal of thrombosis and haemostasis : JTH.

Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high‐responding inhibitors – a thrombin generation‐guided pilot study

G. Kenet, U. Martinowitz, A. Zivelin, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

The Role of Factor XI in Thrombin Generation Induced by Low Concentrations of Tissue Factor

H. Hemker, S. Béguin, A. Zivelin, 2001, Thrombosis and Haemostasis.

Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn.

S. Rapaport, A. Zivelin, U. Seligsohn, 1984, The New England journal of medicine.

Homocysteine and Oxidized Low Density Lipoprotein Enhance Platelet Adhesion to Endothelial Cells under Flow Conditions: Distinct Mechanisms of Thrombogenic Modulation

N. Savion, B. Shenkman, D. Varon, 2000, Thrombosis and Haemostasis.

Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.

A. Zivelin, S. Rapaport, A. Zivelin, 1993, The Journal of clinical investigation.

A relatively high frequency of severe (type III) von Willebrand's disease in Israel

S. Berliner, A. Zivelin, U. Seligsohn, 1986, British journal of haematology.

A common ancestral mutation (C128X) occurring in 11 non‐Jewish families from the UK with factor XI deficiency

R. Mountford, P. Bolton-Maggs, S. Keeney, 2004, Journal of thrombosis and haemostasis : JTH.

ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families.

R. Kaufman, C. Négrier, D. Ginsburg, 1999, Blood.

Combined factors V and VIII deficiency — the solution

R. Kaufman, C. Kessler, D. Ginsburg, 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

Antibody-Induced Acute Factor X Deficiency: Clinical Manifestations and Properties of the Antibody

S. Rapaport, A. Zivelin, S. Rapaport, 1994, Thrombosis and Haemostasis.

The Relative Frequency of Hereditary Thrombotic Disorders Among 107 Patients with Thrombophilia in Israel

A. Zivelin, U. Seligsohn, A. Zivelin, 1989, Thrombosis and Haemostasis.

Factor XIII Deficiency due to a Leu660Pro Mutation in the Factor XIII Subunit-a Gene in Three Unrelated Palestinian Arab Families

V. Yee, B. Brenner, A. Inbal, 1997, Thrombosis and Haemostasis.

A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene.

C. Mannhalter, M. Horellou, A. Zivelin, 1998, Blood.

Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors

G. Kenet, U. Martinowitz, A. Zivelin, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Hereditary deficiency of all vitamin K‐dependent procoagulants and anticoagulants

B. Brenner, B. Brenner, C. Keller, 1990, British journal of haematology.

Combined Factor V and Factor VIII Deficiency among Non-Ashkenazi Jews

A. Zivelin, U. Seligsohn, E. Zwang, 1982 .

Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component.

S. Rapaport, S. Bajaj, A. Zivelin, 1985, Blood.

Evidence for an essential role of tissue factor dependent blood coagulation in the pathogenesis of the local Shwartzman reaction.

A. Zivelin, S. Rapaport, L. Rao, 1995, Blood cells, molecules & diseases.

Thrombophilia as a Multigenic Disorder

A. Zivelin, U. Seligsohn, A. Zivelin, 1997, Thrombosis and Haemostasis.

Hereditary factor XIII deficiency: report of four families and definition of the carrier state

M. Modan, A. Lusky, A. Zivelin, 1984, British journal of haematology.

The feasibility of using concentrates containing factor IX for continuous infusion

S. Schulman, U. Martinowitz, D. Varon, 1995, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin.

S. Rapaport, K. Donnelly, A. Zivelin, 1992, American journal of clinical pathology.

Bleeding predictors in factor‐XI‐deficient patients

A. Laor, B. Brenner, A. Zivelin, 1997, Blood Coagulation and Fibrinolysis.

Partial purification and characterization of extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor).

S. Rapaport, A. Zivelin, A. Zivelin, 1987, Thrombosis research.

Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma

U. Martinowitz, A. Zivelin, U. Seligsohn, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann thrombasthenia in the Iraqi‐Jewish and Arab populations of Israel: comparison of techniques for carrier detection

B. Coller, M. Modan, A. Lusky, 1986, British journal of haematology.

Inherited factor XI deficiency confers no protection against acute myocardial infarction

D. Steinberg, D. Steinberg, B. Ravid, 2003, Journal of thrombosis and haemostasis : JTH.

The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin.

M. Mittelman, O. Shpilberg, B. Brenner, 1997, Blood.

One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews.

A. Chetrit, O. Shpilberg, A. Zivelin, 1995, Blood.

Combined Factor V and Factor VIII Deficiency among Non‐Ashkenazi Jews

A. Zivelin, U. Seligsohn, E. Zwang, 1983, The New England journal of medicine.

Familial factor VII deficiency with foetal and neonatal fatal cerebral haemorrhage associated with homozygosis to Gly180Arg mutation

J. Kapelushnik, A. Zivelin, N. Rosenberg, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Molecular characterization of four novel mutations causing factor VII deficiency.

H. Tamary, R. Zaizov, B. Brenner, 2000, The hematology journal : the official journal of the European Haematology Association.

Fibrinogen levels after inflammation or endotoxin in normal and hypophysectomized rats.

S. Goodnight, A. Zivelin, S. Rapaport, 1975, The American journal of physiology.

Factor VII in plasma of women taking oral contraceptives. Lack of cold activation under blood bank conditions

A. Zivelin, U. Seligsohn, E. Zwang, 1984, Transfusion.

Cold-promoted activation of factor VII: is It a problem under blood bank conditions?

A. Zivelin, U. Seligsohn, S. Bar-Shani, 1983, Haemostasis.

Point mutations regarded as missense mutations cause splicing defects in the factor XI gene

F. Bauduer, A. Zivelin, N. Rosenberg, 2011, Journal of thrombosis and haemostasis : JTH.

The prevalence of factor V G1691A but not of prothrombin G20210A and methylenetetrahydrofolate reductase C677T is remarkably low in French Basques

F. Bauduer, L. Ducout, A. Zivelin, 2004, Journal of thrombosis and haemostasis : JTH.

Detection of Haemophilia A Carriers by Replicate Factor VIII Activity and Factor VIII Antigenicity Determinations

M. Modan, A. Zivelin, U. Seligsohn, 1979, British journal of haematology.

A plasma protein C activity assay suitable for a clinical laboratory. Its use to measure activity in hereditary and acquired deficiency states.

S. Rapaport, K. Donnelly, A. Zivelin, 1987, American journal of clinical pathology.

Geographic Distribution of the 20210 G to A Prothrombin Variant

P. Reitsma, D. Siscovick, F. Rosendaal, 1998, Thrombosis and Haemostasis.

Immunoblot analysis of platelet glyeoprotein IIb in patients with Glanzmann thrombasthenia in Israel

B. Coller, M. Ginsberg, E. Plow, 1989, British journal of haematology.

Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction.

H. Hod, M. Modan, G. Barbash, 1989, The American journal of cardiology.

Plasma PIVKA proteins in rabbits given warfarin.

A. Zivelin, S. Rapaport, L. Rao, 1996, Thrombosis research.